As per this research, the primary treatment method is supplementation with vitamin B12
Mounjaro, Zepbound, and the GLP-1-only authorized products contain different active ingredients (tirzepatide, semaglutide), not retatrutide
At Focal Point Vitality it is used only within a physician-supervised program
Human safety, efficacy, dosing, and clinical utility havent been established
It remains a research compound that some clinics and individuals have begun using despite the lack of regulatory approval
Second, when two sources differ by that much, at least one of them is not describing what it claims to describe